Julia Maria Ressler

10PUBLICATIONS
45CO-AUTHORS
Immunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 02, 2026
Severe Immune-Related Neurological Adverse Events Associated With Immune Checkpoint Inhibitor Treatment: A Retrospective Single-Center Study.

|Jan 17, 2025
Efficacy and tolerability of neoadjuvant therapy with Talimogene laherparepvec in cutaneous basal cell carcinoma: a phase II trial (NeoBCC trial).

Julia Maria Ressler, Maud Plaschka, Rita Silmbrod

|Sep 28, 2024
BRAF Inhibition and UVB Light Synergistically Promote Mus musculus Papillomavirus 1-Induced Skin Tumorigenesis.

Sonja Dorfer, Julia Maria Ressler, Katharina Riebenbauer

|Jun 05, 2024
Off-targets of BRAF inhibitors disrupt endothelial signaling and vascular barrier function.

Sophie Bromberger, Yuliia Zadorozhna, Julia Maria Ressler

|Mar 08, 2024
Regulation of the Immune Cell Repertoire in Psoriasis Patients Upon Blockade of IL-17A or TNFα.

Julia Tittes, Jennifer Brell, Pia Fritz

|Apr 12, 2023
Cutaneous manifestations induced by check point inhibitors in 120 melanoma patients-The European MelSkinTox study.

J-M L'Orphelin, J Cassecuel, L Kandolf

Pageof 2

Frequent Collaborators

3 joint publications

Nina Zila

3 joint publications

Christoph Hoeller

2 joint publications

Peter Petzelbauer

2 joint publications

Victoria Bachmayr